Association of aortic valve calcification and vitamin K antagonist treatment

Pernille Stegemejer Sønderskov, Jes Sandal Lindholt, Jesper Hallas, Oke Gerke, Selma Hasific, Jess Lambrechtsen, Flemming Hald Steffensen, Martin Busk, Lars Frost, Grazina Urbonaviciene, Marek Karon, Abdel Monem Kikar, Lars Melholt Rasmussen, Axel Diederichsen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

AIMS : Vitamin K antagonists (VKAs) are suspected of causing aortic valve calcification (AVC). The objective of this study was to clarify whether patients undergoing VKA treatment have increased AVC scores compared to patients treated with new oral anticoagulants (NOACs) and patients who never have been treated with VKA/NOAC.

METHODS AND RESULTS : We included participants from the population-based DANCAVAS trial (n = 15 048). Information on confounders was collected, and the AVC scores were measured on non-contrast computed tomography scans. The participants' medication data, including VKA and NOAC data, were collected from the Danish National Health Service Prescription Database. The final population consisted of 14 604 participants (67.4 years, 95% men) of whom 873 had been treated with VKA and 602 with NOAC. The association between AVC score and duration of anticoagulant use was investigated in an adjusted zero-inflated negative binomial regression model. For every year treated with VKA, the AVC score increased, on average, by 6% [ratio of expected counts (RECs) = 1.06; 95% confidence interval (CI) 1.02-1.10] compared to non-use. The results were consistent in sensitivity analyses excluding patients with known cardiovascular disease and statin users (REC = 1.07; 95% CI 1.02-1.11 and REC = 1.10; 95% CI 1.03-1.17, respectively). NOAC treatment was not significantly associated with AVC score in any of the corresponding models (REC = 1.03, 1.02, and 0.96).

CONCLUSION : Compared to no treatment with anticoagulants, VKA use was associated with increased AVC score, while a similar association could not be established for NOAC.

OriginalsprogEngelsk
TidsskriftEuropean Heart Journal Cardiovascular Imaging
Vol/bind21
Udgave nummer7
Sider (fra-til)718-724
ISSN2047-2404
DOI
StatusUdgivet - 3. maj 2020

Bibliografisk note

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Fingeraftryk Dyk ned i forskningsemnerne om 'Association of aortic valve calcification and vitamin K antagonist treatment'. Sammen danner de et unikt fingeraftryk.

Citationsformater